Roche's strategic acquisition of Poseida Pharmaceuticals positions them as a leader in the allogeneic cell therapy market.

Under their brand names Wegovy (for obesity) and Ozempic (for Type 2 Diabetes), and Zepbound / Mounjaro, semaglutide and tirzepatide are ... mechanisms of action ("MoA") and a personal opinion ...

On Monday, former four-star BYU linebacker Aisea Moa committed to the Michigan State Spartans, as reported by On3's Jason Killop. Moa and his family (including high four-star offer Salesi ...

If you’re starting a weight loss journey, you might have stumbled upon tirzepatide — the drug approved by the FDA (U.S. Food and Drug Administration) under the brand names Mounjaro and Zepbound.

The profitability screen requires that the sum of a company’s GAAP earnings over the past four quarters be positive as well as the most recent quarter. The screen imparts a slight quality tilt ...

UAE -- The U.S. Food and Drug Administration (FDA) approved lately Tirzepatide, produced by Eli Lilly, as the first and only prescription medicine for adults with moderate-to-severe obstructive sleep ...

MoA Aggressive Allocation Fund earns a High Process Pillar rating. The most important driver of the rating is its parent firm's impressive long-term risk-adjusted performance, as shown by the firm ...

Medications like semaglutide and tirzepatide have gained significant attention for their impressive weight-loss effects, but they do much more than just helping you shed pounds. Let’s dive into ...

The FDA has announced that popular weight loss medication tirzepatide is no longer in shortage, potentially removing cheaper versions of the drug from the market by early 2025. Tirzepatide is the ...